Company page
Eupraxia Pharmaceuticals, Inc.
Eupraxia Pharmaceuticals, Inc. is a public company listed on the Canadian market under the ticker EPRX. The company has a market capitalization of approximately CAD 423.7 million. Eupraxia focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- EPRX:TSX
- Asset type
- Stock
- Market cap
- $423.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TSX
- Currency
- CAD